• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 3. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 4. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 5. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219

4-Oxo-4-(4-propylphenyl)butanoic Acid (CAS No. 57821-78-0): A Comprehensive Guide

4-Oxo-4-(4-propylphenyl)butanoic Acid (CAS No. 57821-78-0) is a specialized organic compound that has garnered significant attention in pharmaceutical and chemical research. This keto acid derivative features a unique molecular structure combining a propylphenyl group with a butanoic acid backbone, making it valuable for various synthetic applications. Researchers often refer to it as 4-(4-propylbenzoyl)butyric acid, highlighting its functional groups.

The compound's molecular formula C13H16O3 and molecular weight 220.26 g/mol position it as an intermediate in organic synthesis. Its keto group at position 4 and carboxylic acid functionality make it particularly reactive for condensation reactions and ester formation. Recent studies in medicinal chemistry have explored its potential as a building block for drug development, especially in creating non-steroidal anti-inflammatory drug (NSAID) analogs.

In pharmaceutical applications, 4-Oxo-4-(4-propylphenyl)butanoic Acid serves as a precursor for compounds with potential biological activity. The propylphenyl moiety contributes to lipophilicity, which can enhance membrane permeability in drug candidates. Current research trends focus on its use in developing targeted therapies, particularly in inflammation-related pathways, aligning with growing interest in precision medicine approaches.

The chemical's physical properties include a white to off-white crystalline appearance with typical melting points between 98-102°C. Its solubility profile shows moderate solubility in organic solvents like ethanol and acetone, but limited water solubility, which is characteristic of aromatic carboxylic acids. These properties make it suitable for various organic synthesis conditions while requiring proper handling in laboratory settings.

From a market perspective, demand for 4-Oxo-4-(4-propylphenyl)butanoic Acid has steadily increased due to its applications in pharmaceutical intermediates. The compound's relevance has grown alongside advancements in small molecule drug discovery, particularly in academic and industrial research settings. Manufacturers typically supply it in quantities ranging from grams to kilograms, with purity levels exceeding 98% for research applications.

Quality control for 57821-78-0 involves rigorous analytical methods including HPLC analysis, mass spectrometry, and NMR spectroscopy to verify structural integrity and purity. These analytical techniques ensure the compound meets the stringent requirements of pharmaceutical-grade materials, addressing the increasing regulatory standards in drug development pipelines.

Environmental and safety considerations for 4-Oxo-4-(4-propylphenyl)butanoic Acid follow standard laboratory chemical protocols. While not classified as highly hazardous, proper personal protective equipment (PPE) including gloves and safety glasses is recommended during handling. The compound's biodegradability and ecotoxicity profile have become increasingly important evaluation criteria, reflecting the pharmaceutical industry's focus on green chemistry principles.

Recent scientific literature highlights novel synthetic routes to 4-Oxo-4-(4-propylphenyl)butanoic Acid that improve yield and reduce environmental impact. These advancements align with the broader trend toward sustainable chemical synthesis in pharmaceutical manufacturing. Researchers have developed catalytic methods that minimize waste generation while maintaining high selectivity for the target compound.

The compound's structural features make it valuable for structure-activity relationship (SAR) studies in medicinal chemistry. Its aromatic ring system and flexible side chain allow for diverse molecular modifications, facilitating the exploration of new bioactive compounds. This versatility contributes to its ongoing relevance in drug discovery programs targeting various therapeutic areas.

Looking forward, 4-Oxo-4-(4-propylphenyl)butanoic Acid maintains its position as an important chemical building block in pharmaceutical research. Its applications continue to expand as scientists develop new synthetic methodologies and discover novel biological activities for its derivatives. The compound exemplifies how specialty chemicals contribute to advancements in healthcare and materials science, addressing current challenges in drug development and molecular design.

• 2051-95-8(3-Benzoylpropionic acid)
• 4619-20-9(4-(4-Methylphenyl)-4-oxobutanoic Acid)
• 1501-05-9(5-Oxo-5-phenylpentanoic acid)
• 16269-05-9(9-Oxo-9-phenylnonanoic acid)
• 100117-48-4(Benzenebutanoic acid, 4-acetyl-)
• 7472-43-7(7-Oxo-7-phenylheptanoic acid)
• 49594-75-4(4-Ethyl-γ-oxobenzenebutanoic Acid)
• 4144-62-1(5-Benzoylpentanoic acid)
• 178686-76-5(5-Oxo-5-(4-n-pentylphenyl)valeric acid)
• 114150-57-1(4,6-Dioxo-6-phenylhexanoic acid)